Literature DB >> 21248755

Association between human metapneumovirus seroprevalence and hypertension in elderly subjects in a long-term care facility.

Li Zeng1, Rui Chen, Keiichiro Ishigami, Mikiko Atsumi, Yumi Koizumi, Kazuto Sato, Osamu Iritani, Masashi Okuro, Shigeto Morimoto.   

Abstract

Recently, relations between hypertension and infections caused by several pathogens have been reported. However, few studies have examined the relationship between human metapneumovirus (hMPV) and hypertension in elderly inpatients. To assess the association between anti-hMPV-immunoglobulin G (IgG) titer and the prevalence of hypertension, we conducted a case-control study in a Japanese long-term care facility (LTCF). The participants included 84 hypertensive patients aged 65 years, and 84 age- and sex-matched normotensive controls (38 males and 46 females in each group; cases, 79.9±8.4 (s.d.) years; controls, 80.1±8.3 years). Data on underling chronic clinical conditions were collected. Titers were measured using an immunofluorescence assay kit. The significance of risk factor differences was analyzed using univariate and multivariate comparisons of cases and controls. All serum samples were positive for hMPV, and IgG titers ranged from 40-fold to more than 5120-fold. There were no significant sex- or age-related differences in log(2) (anti-hMPV-IgG titer/10) among the subjects. Compared with normotensive subjects, hypertensive patients presented significantly higher log(2) (anti-hMPV-IgG titer/10) values (P<0.001). After adjustment with multiple logistic analysis, the odds ratio for log(2) (anti-hMPV-IgG titer/10) was 1.42 (95% confidence interval 1.16-1.75, P=0.001) relative to normotensive subjects. In all subjects, stepwise multiple regression analysis revealed that both hypertension and a poor nutritional state independently contributed to increased log(2) (anti-hMPV-IgG titer/10). These observations suggest that an increased anti-hMPV-IgG titer was closely related to hypertension in elderly subjects in a Japanese LTCF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248755     DOI: 10.1038/hr.2010.268

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  5 in total

Review 1.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 2.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Association of severe hypertension with pneumonia in elderly patients with acute ischemic stroke.

Authors:  Keiichiro Ishigami; Masashi Okuro; Yumi Koizumi; Kazuto Satoh; Osamu Iritani; Hiroshi Yano; Toshihiro Higashikawa; Kunimitsu Iwai; Shigeto Morimoto
Journal:  Hypertens Res       Date:  2012-02-09       Impact factor: 3.872

4.  Acute Myopericarditis caused by Human Metapneumovirus.

Authors:  Min Joo Choi; Joon Young Song; Tae Un Yang; Ji Ho Jeon; Ji Yun Noh; Kyung Wook Hong; Hee Jin Cheong; Woo Joo Kim
Journal:  Infect Chemother       Date:  2016-03-31

5.  Pericardial Effusion and Tamponade Complicating Acute Pericarditis in a Human Metapneumovirus-Infected Adult: A Unique Case Report.

Authors:  Nawfal Mihyawi; Ayman R Fath; Dawood Findakly; Arnold Forlemu; Raina R Roy
Journal:  Cureus       Date:  2020-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.